Search hospitals

>

Quebec

>

MONTREAL

The Montreal Children's Hospital of the MUHC

Claim this profile

MONTREAL, Quebec H3H 1P3

Global Leader in Brain Tumor

Global Leader in Acute Lymphoblastic Leukemia

Conducts research for Leukemia

Conducts research for Solid Tumors

Conducts research for Cancer

254 reported clinical trials

12 medical researchers

Photo of The Montreal Children's Hospital of the MUHC in MONTREALPhoto of The Montreal Children's Hospital of the MUHC in MONTREALPhoto of The Montreal Children's Hospital of the MUHC in MONTREAL

Summary

The Montreal Children's Hospital of the MUHC is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Brain Tumor, Acute Lymphoblastic Leukemia, Leukemia, Solid Tumors, Cancer and other specialties. The Montreal Children's Hospital of the MUHC is involved with conducting 254 clinical trials across 468 conditions. There are 12 research doctors associated with this hospital, such as Sharon B. Abish, Genevieve Legault, MD, Pia Wintermark, MD, and Catherine Vezina, MD.

Area of expertise

1

Brain Tumor

Global Leader

The Montreal Children's Hospital of the MUHC has run 42 trials for Brain Tumor. Some of their research focus areas include:

Stage IV
Stage I
Stage II
2

Acute Lymphoblastic Leukemia

Global Leader

The Montreal Children's Hospital of the MUHC has run 37 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:

Stage II
Stage IV
Stage III

Top PIs

Clinical Trials running at The Montreal Children's Hospital of the MUHC

Brain Tumor

Diffuse Intrinsic Pontine Glioma

Testicular cancer

Glioblastoma

Brain Cancer

Neuroblastoma

Ovarian Carcinoma

Ovarian Tumors

Testicular Carcinoma

Ovarian Choriocarcinoma

Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.

Recruiting

2 awards

Phase 3

Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.

Recruiting

1 award

Phase 2

10 criteria

Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at The Montreal Children's Hospital of the MUHC?